Figure 10

2D and 3D-interactions of compounds with targeted proteins. (A) P53/Heptanediamide, N,Nʹ-di-benzoyloxy; (B) p53/2-[4-Methyl-6-(2,6,6-trimethyl-cyclohex-1-enyl)hexa-1,3,5-trienyl]cyclohex-1-en-1-carboxaldehyde; (C) BCL2/Cycloartenol; (D) BCL2/Obtusifoliol.